Clinical and biochemical predictors of efficacy of and side effects from azathioprine in patients with inflammatory bowel disease (IBD)

被引：1
|
作者：
McGovern, DP
Hussaini, H
Worthington, J
Reynolds, NJ
Shobowale-Bakre, EM
Duley, JA
Dalton, HR
机构：
[1] Royal Cornwall Hosp, Gastrointestinal Unit, Truro, Cornwall, England
[2] Royal Victoria Infirm, Dept Dermatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[3] Acad & St Thomas Hosp, Purine Res Lab, London, England
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)85294-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4206
引用
收藏
页码：A788 / A788
页数：1
相关论文
共 50 条
  • [21] Short and Long-Term Effectiveness of Azathioprine and Mercaptopurine in Patients With Inflammatory Bowel Disease (IBD)
    Castano-Milla, Carlos
    Chaparro, Maria
    Mate, J.
    Gisben, Javier P.
    GASTROENTEROLOGY, 2011, 140 (05) : S592 - S592
  • [22] A study to evaluate the Clinical, Pharmacogenomic and metabolomic predictors of efficacy and safety of Azathioprine therapy in patients with IBD
    Sarma, Phulen
    Kochhar, Rakesh
    Dutta, Usha
    Muktesh, Gauraav
    Soni, Shringika
    Kumar, Subodh
    Singh, Rahul
    Kumar, Harish
    Dhaka, Narender
    Patial, Ajay
    Mishra, Abhishek
    Singh, Ashutosh
    Attri, Savita Verma
    Medhi, Bikash
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 243 - 243
  • [23] A Pharmacogenetics Study of TPMT and ITPA Genes Detects a Relationship with Side Effects and Clinical Response in Patients with Inflammatory Bowel Disease Receiving Azathioprine
    Zabala-Fernandez, William
    Barreiro-de Acosta, Manuel
    Echarri, Ana
    Carpio, Daniel
    Lorenzo, Aurelio
    Castro, Javier
    Martinez-Ares, David
    Pereira, Santos
    Martin-Granizo, Ignacio
    Corton, Marta
    Carracedo, Angel
    Barros, Francisco
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2011, 20 (03) : 247 - 253
  • [24] AWARENESS OF ADVERSE EFFECTS OF AZATHIOPRINE AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Spence, A. D.
    Lee, R.
    Keegan, D.
    Doherty, G. A.
    Mulcahy, H.
    O'Donoghue, D.
    Murphy, S. J.
    GUT, 2013, 62
  • [25] Clinical implications of thiopurine-methyltransferase activity (TPMTe) induction of azathioprine (AZA) treatment in patients with inflammatory bowel disease (IBD)
    Domenech, E
    Garcia-Planella, E
    Fluvia, L
    Bernal, I
    Cabre, E
    Gassull, M
    GASTROENTEROLOGY, 2003, 124 (04) : A195 - A195
  • [26] Safety issues of azathioprine in patients with inflammatory bowel disease: clinical experience from a referral center
    Fousekis, F.
    Kourtis, G.
    Saridi, M.
    Albani, E.
    Katsanos, K.
    Christodoulou, D.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I372 - I372
  • [27] Safety issues of azathioprine in patients with inflammatory bowel disease: clinical experience from a referral center
    Fousekis, F.
    Kourtis, G.
    Saridi, M.
    Albani, E.
    Katsanos, K.
    Christodoulou, D.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I372 - I372
  • [28] THE REALITY OF THE TOLERANCE AND EFFICACY OF ORAL IRON IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)
    Beal, F.
    Lugg, S.
    Rattehalli, D.
    Tselepis, C.
    Iqbal, T.
    GUT, 2012, 61 : A179 - A180
  • [29] Interaction between aminosalicylates and azathioprine (AZA): An ex vivo study in patients with inflammatory bowel disease (IBD)
    Xin, H
    Fischer, C
    Schwab, M
    Klotz, U
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R142 - R142
  • [30] Risk of Relapse After Azathioprine (AZA) Discontinuation in Inflammatory Bowel Disease (IBD) Patients in Maintained Remission
    Iborra, Marisa
    Herreras, Julia
    Bosca-Watts, Marta M.
    Cortes, Xavier
    Navarro, Belen
    Martinez, Maria Teresa Blazquez
    Trejo, Galo A.
    Beltran, Belen
    Nos, Pilar
    GASTROENTEROLOGY, 2016, 150 (04) : S442 - S442
12345